Sesame Therapeutics is a precision oncology company developing novel cancer medicines with wide therapeutic windows. It transforms highly validated but pan-lethal targets into selective therapies by engineering selective lethality within cancer-specific protein neighborhoods and leveraging inherent molecular proximity to discover first-in-class small molecules.